Related Experiment Videos
Pediatric Non-Alcoholic Fatty Liver Disease
Edgard Delvin1, Natasha Patey2, Josée Dubois3
1Departement of Biochemistry, University of Montreal, Montreal, Quebec, Canada; CHU Sainte-Justine Research Center, University of Montreal, Montreal, Quebec, Canada.
Journal of Medical Biochemistry
|March 31, 2017
Summary
Childhood obesity is rising, leading to serious health issues like metabolic syndrome and non-alcoholic fatty liver disease (NAFLD). Close monitoring of these trends is crucial for public health.
Area of Science:
- Pediatrics
- Public Health
- Metabolic Disorders
Background:
- Childhood obesity prevalence is increasing globally.
- Associated co-morbidities include hypertriglyceridemia, hyper-insulinemia, hypertension, and early atherosclerosis.
- Metabolic syndrome and non-alcoholic fatty liver disease (NAFLD) are significant concerns in pediatric populations.
Purpose of the Study:
- To highlight the public health concerns associated with rising childhood obesity.
- To emphasize the need for monitoring trends in child and adolescent obesity.
- To project the future increase in young adults with metabolic syndrome and NAFLD.
Main Methods:
- This study is a review and analysis of current public health data and trends.
- Epidemiological data on childhood obesity and associated co-morbidities were examined.
- Longitudinal trends and future projections were considered.
Main Results:
- Childhood obesity is rapidly increasing worldwide.
- Associated co-morbidities are becoming more prevalent in children and adolescents.
- A significant rise in young adults with metabolic syndrome and NAFLD is anticipated.
Conclusions:
- Childhood obesity poses a major public health threat.
- Continued monitoring of obesity trends in children and adolescents is essential.
- Early intervention and management are critical to prevent long-term metabolic complications and NAFLD progression to non-alcoholic steatohepatitis.